Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Annales De Pathologie|February 19, 2025
[Case #4. Cytology with atypical urothelial cells]Eva Compérat
Current Opinion in Urology|August 28, 2019
Evolution of prostate cancer histopathologyEva Compérat
Annales De Pathologie|October 22, 2008
[Case 6. Perspectives in 2007 for bladder pathology. High-grade urothelial carcinoma with tumor nests]Eva Compérat
Annales De Pathologie|April 8, 2014
[Rare renal tumors. Case no 7. "Atypical" oncocytoma: how many atypia can we accept?]Eva Compérat
Annales De Pathologie|April 8, 2014
[Rare renal tumors. Case No 8. Collision tumors and multiple tumors]Eva Compérat
European Urology|January 17, 2018
Changes of Tumour-Node-Metastasis Staging in 2017: Concepts and Evolutions in the European and American ContinentsEva Compérat
European Urology|July 8, 2020
Re: Greater Utility of Molecular Subtype Rather than Epithelial-to-mesenchymal Transition (EMT) Markers for Prognosis in High-risk Non-muscle-invasive (HGT1) Bladder CancerEva Compérat
Ceskoslovenska Patologie|November 25, 2014
Update on urinary bladder pathologyEva Compérat
Annales De Pathologie|May 31, 2017
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n<sup>o</sup> 2: Prostatic adenocarcinoma, pleomorphic giant cell variant]Eva Compérat
European Journal of Cancer (Oxford, England : 1990)|February 23, 2021
Editorial for Cribriform architecture prostatic adenocarcinoma in needle biopsy is a strong independent predictor for lymph node metastases in radical prostatectomy (M. Downes et al.) and Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival (K. Chow et al.)Eva Compérat
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Annales De Pathologie|February 19, 2025
[Case #4. Cytology with atypical urothelial cells]Eva Compérat
Current Opinion in Urology|August 28, 2019
Evolution of prostate cancer histopathologyEva Compérat
Annales De Pathologie|October 22, 2008
[Case 6. Perspectives in 2007 for bladder pathology. High-grade urothelial carcinoma with tumor nests]Eva Compérat
Annales De Pathologie|April 8, 2014
[Rare renal tumors. Case no 7. "Atypical" oncocytoma: how many atypia can we accept?]Eva Compérat
Annales De Pathologie|April 8, 2014
[Rare renal tumors. Case No 8. Collision tumors and multiple tumors]Eva Compérat
European Urology|January 17, 2018
Changes of Tumour-Node-Metastasis Staging in 2017: Concepts and Evolutions in the European and American ContinentsEva Compérat
European Urology|July 8, 2020
Re: Greater Utility of Molecular Subtype Rather than Epithelial-to-mesenchymal Transition (EMT) Markers for Prognosis in High-risk Non-muscle-invasive (HGT1) Bladder CancerEva Compérat
Ceskoslovenska Patologie|November 25, 2014
Update on urinary bladder pathologyEva Compérat
Annales De Pathologie|May 31, 2017
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n<sup>o</sup> 2: Prostatic adenocarcinoma, pleomorphic giant cell variant]Eva Compérat
European Journal of Cancer (Oxford, England : 1990)|February 23, 2021
Editorial for Cribriform architecture prostatic adenocarcinoma in needle biopsy is a strong independent predictor for lymph node metastases in radical prostatectomy (M. Downes et al.) and Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival (K. Chow et al.)Eva Compérat
Pageof 25